Form 4: Esperion Therapeutics General Counsel Sells Shares for Tax Obligations
Insider Transaction Report
Esperion Therapeutics' General Counsel, Benjamin Looker, sold 1,304 shares of common stock to cover tax obligations related to vested restricted stock units.
Summary
- Benjamin Looker, General Counsel of Esperion Therapeutics, Inc. (ESPR), reported a transaction on July 17, 2025.
- Looker disposed of 1,304 shares of Esperion Therapeutics Common Stock at a price of $1.127 per share.
- The sale was conducted to satisfy tax obligations arising from the vesting of restricted stock units.
- Following this transaction, Benjamin Looker beneficially owns 399,937 shares of Esperion Therapeutics Common Stock.
Sentiment
Score: 5
Explanation: The transaction is a routine sale to cover tax obligations on vested equity, which is a neutral event and does not indicate a change in management's confidence or company performance.
Industry Context
This filing is a routine insider transaction report, common for executives who receive equity compensation. It does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Establishment of Power of Attorney | Benjamin Looker granted a Limited Power of Attorney to Sheldon Koenig and Richard Bartram, authorizing them to execute and file SEC forms (Form ID, 3, 4, 5, Schedule 13D) on his behalf as an officer and/or director of Esperion Therapeutics, Inc. | 12/13/2021 | Streamlines the process for timely and compliant SEC filings for the reporting person, ensuring adherence to Section 16 and Regulation 13D-G of the Securities Exchange Act of 1934. |
Stakeholder Impact
- Shareholders: The sale of a small number of shares for tax purposes by an executive is a routine event and typically has minimal direct impact on shareholder value or perception.
Key Dates
| Date | Description |
|---|---|
| 12/13/2021 | Date Benjamin Looker executed the Limited Power of Attorney. |
| 07/17/2025 | Date of the reported transaction (sale of common stock). |
| 07/18/2025 | Date the Form 4 filing was signed by power of attorney. |
Keywords
Esperion Therapeutics, ESPR, Form 4, Insider Trading, Stock Sale, Tax Obligation, Restricted Stock Units, General Counsel, Benjamin Looker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.